How severe is CVE-2024-48654?

CVE-2024-48654 has a CVSS 3.x base score of 6.1, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.

Is CVE-2024-48654 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (30th percentile), an estimate of the probability of exploitation in the next 30 days.

How do I fix CVE-2024-48654?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

Does CVE-2024-48654 have an EU (EUVD) identifier?

Yes. CVE-2024-48654 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-43062.

When was CVE-2024-48654 published?

CVE-2024-48654 was published on 2024-10-25 and last updated on 2026-06-17.

CVE-2024-48654

CVE-2024-48654 is a medium-severity vulnerability with a CVSS 3.x base score of 6.1. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.

Key facts

Severity: Medium (CVSS 3.x base score 6.1)
EPSS exploit prediction: 0% (30th percentile)
Actively exploited: Not listed in CISA KEV
EU (EUVD) id: EUVD-2024-43062
Weakness: CWE-79
Published: 2024-10-25
Last modified: 2026-06-17

Description

Cross Site Scripting vulnerability in Blood Bank v.1 allows a remote attacker to execute arbitrary code via a crafted script to the login.php component.

Frequently asked questions

What is CVE-2024-48654?: Cross Site Scripting vulnerability in Blood Bank v.1 allows a remote attacker to execute arbitrary code via a crafted script to the login.php component.
How severe is CVE-2024-48654?: CVE-2024-48654 has a CVSS 3.x base score of 6.1, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2024-48654 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (30th percentile), an estimate of the probability of exploitation in the next 30 days.
How do I fix CVE-2024-48654?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2024-48654 have an EU (EUVD) identifier?: Yes. CVE-2024-48654 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-43062.
When was CVE-2024-48654 published?: CVE-2024-48654 was published on 2024-10-25 and last updated on 2026-06-17.

References

Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities

CVE-2025-49410 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Imran Emu TC…
CVE-2024-47875 — Critical (CVSS 10.0): DOMPurify is a DOM-only, super-fast, uber-tolerant XSS sanitizer for HTML, MathML and SVG. DOMpurify was vulnerable to…
CVE-2024-6886 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Gitea…
CVE-2023-45144 — Critical (CVSS 10.0): com.xwiki.identity-oauth:identity-oauth-ui is a package to aid in building identity and service providers based on…
CVE-2023-45138 — Critical (CVSS 10.0): Change Request is an pplication allowing users to request changes on a wiki without publishing the changes directly.…
CVE-2022-4361 — Critical (CVSS 10.0): Keycloak, an open-source identity and access management solution, has a cross-site scripting (XSS) vulnerability in the…

Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →